August 7, 2017 / 9:14 PM / 2 years ago

BRIEF-Coherus Biosciences Q2 loss $1.08 per share

Aug 7 (Reuters) - Coherus Biosciences Inc:

* Anticipate resubmitting BLA in U.S. At end of Q4 of 2017 for CHS-1701

* Coherus Biosciences reports second quarter 2017 corporate highlights and financial results

* Q2 revenue $1.4 million versus $14.1 million

* Q2 revenue view $5.2 million — Thomson Reuters I/B/E/S

* Q2 loss per share $1.08

* Q2 earnings per share view $-1.20 — Thomson Reuters I/B/E/S

* Anticipates cash usage of about $40 - $45 million per quarter in h2 2017 and $30 - $35 million per quarter in first half of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below